Sveriges mest populära poddar
JAMA Clinical Reviews
Hälsa och motionMedicin

Renal Cell Carcinoma

21 min•28 augusti 2024

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.

Related Content:

Fler avsnitt av JAMA Clinical Reviews

Visa alla avsnitt av JAMA Clinical Reviews
Evaluating for Pediatric Concussion
•16 min
Iron Deficiency in Adults: Advances in Diagnosis and Treatment
•17 min
From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
•15 min
Resistant Hypertension: Diagnosis and Management
•18 min
Update on Peanut Allergy
•19 min
Obesity-Related Cancer
•21 min
Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
•20 min
Does This Patient Have Volume Overload? The Rational Clinical Examination
•19 min
Type 1 Diabetes: Diagnosis and Management
•17 min
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
•33 min

JAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.